Benlysta
Payments companies reported to CMS as associated with Benlysta. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Benlysta, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Benlysta
These are the largest totals companies reported as associated with Benlysta. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Donald Thomas | Greenbelt, MD | Rheumatology | $172,690.09 |
| Irfan Agha | Dallas, TX | Nephrology (Internal Medicine) | $166,227.76 |
| Julio Gonzalez-Paoli | Tampa, FL | Rheumatology | $118,860.85 |
| Guillermo Valenzuela | Plantation, FL | $101,812.20 | |
| Maureen Mcmahon | Los Angeles, CA | Rheumatology | $91,742.22 |
| Kristi Mizelle | Newport News, VA | Rheumatology | $91,169.58 |
| Rhonda Lambert | San Mateo, CA | Rheumatology | $86,192.41 |
| Leanna Wise | Los Angeles, CA | Rheumatology | $83,857.44 |
| Alfred Kim | Saint Louis, MO | Rheumatology | $79,683.53 |
| Joanna Geslani | Dallas, TX | Rheumatology | $75,326.29 |
Prescribed Benlysta?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.